New stent study aims to improve heart artery treatment
NCT ID NCT07563231
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at a special stent (a small mesh tube) coated with a drug called sirolimus, used to open blocked heart arteries. Researchers will follow 300 adults who received this stent during a standard heart procedure to see how safe and effective it is over 5 years. The main goal is to check if the treated artery stays open without problems like heart attack or needing another procedure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Geneva University Hospitals (HUG) - Service of Cardiology
Geneva, 1211, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Can immune cells predict how well the heart heals after an attack?
- Heart patients may stay active longer with coach calls and group support
- Could a hot bath after exercise help heal the heart?
- Can a Plant-Based diet calm the immune system after a heart attack?
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program